In a significant advancement for cancer care in Northern India, Lucknow's Kalyan Singh Super Speciality Cancer Institute inaugurated a cutting-edge CyberKnife robotic radiosurgery system on Tuesday. This installation represents a major leap forward in providing sophisticated, non-invasive treatment options for cancer patients across the region.
Revolutionary Technology for Precision Treatment
The CyberKnife system was officially unveiled by the institute's director, Professor MLB Bhatt. This advanced medical device is designed to deliver high-dose radiation with exceptional sub-millimetre accuracy, effectively targeting tumours while meticulously protecting surrounding healthy tissues.
How the CyberKnife System Works
The system employs a robotic arm-mounted linear accelerator that administers radiation from hundreds of different angles. This multi-directional approach ensures highly personalised and precise treatment tailored to each patient's unique anatomical structure.
Key technological features include:
- Real-time tumour tracking capabilities
- Synchrony motion management technology that adjusts radiation delivery according to natural body movements
- Elimination of the need for surgical incisions or rigid immobilisation devices
Patient Benefits and Treatment Scope
Professor Bhatt emphasised that this technology enables treatment of complex tumours without traditional surgery, typically requiring just 1 to 5 sessions. Patients can often resume normal activities on the same day as treatment, experiencing minimal side effects.
The CyberKnife system has demonstrated effectiveness in treating tumours located in:
- Brain
- Spine
- Lungs
- Liver
- Pancreas
- Prostate
- Other complex anatomical regions
Regional Impact and Operational Timeline
This advanced installation is expected to benefit cancer patients not only from Uttar Pradesh but also from neighbouring states, reducing the need for patients to travel long distances for sophisticated treatment options.
Medical Superintendent Dr Varun Vijay clarified that the CyberKnife system will become operational following mandatory testing and approval from the Atomic Energy Regulatory Board (AERB). This regulatory process is anticipated to take approximately 2 to 3 months before the machine can begin treating patients.
The introduction of this technology at Kalyan Singh Super Speciality Cancer Institute positions Lucknow as a growing hub for advanced cancer care in Northern India, offering hope and improved treatment outcomes for countless patients facing complex oncological challenges.
